PHI - Phase Holographic Imaging » Articles & Book Chapters » Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform

Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform

The faseb journal , 2015 | Shravan Kumar Sriraman, Yilin Zhang, Ernst Lengyel and Vladimir Torchilin

Using time-course holographic imaging studies, this cell cycle arrest followed by progression to apoptosis was clearly visualized and confirmed.

Read more
Design by Clavis Communications